Associated Papers
Mechanisms of NLRP3 activation and inhibition elucidated by functional analysis of disease-associated variants.
Feng S et al.
Nature Immunology, 2025
39930093 (PubMed )
Supplement: 41590_2025_2088_MOESM3_ESM.xlsx › Table_1
Novel chemotype NLRP3 inhibitors that target the CRID3-binding pocket with high potency.
Vande Walle L et al.
Life Science Alliance, 2024
HSP90β controls NLRP3 autoactivation.
Spel L et al.
Science Advances, 2024
38416826 (PubMed )
Supplement: sciadv.adj6289_sm.pdf
Clinical characteristics of Chinese neonates with neonatal-onset multisystem inflammatory disease: a case report and literature review.
Zhao C et al.
Frontiers in Immunology, 2023
Tumor necrosis factor-alpha blockade ameliorates inflammatory response in two children with chronic infantile neurological, cutaneous and articular syndrome.
Luo XY et al.
The Journal of Dermatology, 2020
Next-generation sequencing and its initial applications for molecular diagnosis of systemic auto-inflammatory diseases.
Rusmini M et al.
Annals of the Rheumatic Diseases, 2016
Select a paper to view details